Arabesque Asset Management LTD Halozyme Therapeutics, Inc. Transaction History

Arabesque Asset Management LTD

  • $0
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$37.35 - $48.3 $292,039 - $377,657
7,819 New
7,819 $344,000
Q3 2020

Nov 16, 2020
SELL
$25.74 - $29.63 $3.32 Million - $3.82 Million
-128,961 Closed
0 $0
Q2 2020

Oct 22, 2020
BUY
$16.25 - $26.81 $2.1 Million - $3.46 Million
128,961 New
128,961 $3.46 Million

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Arabesque Asset Management LTD Portfolio

Follow Arabesque Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Arabesque Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email